NDAORALFOR SUSPENSION
Approved
Aug 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
AUGMENTIN '125' (amoxicillin and clavulanate potassium) by Pfizer is [see microbiology ( )] . Approved for the following infections in adults, skin structure infections urinary tract infections limitations of use, indicating no beta-lactamase production and 11 more indications. First approved in 1984.
Drug data last refreshed 20h ago
Mechanism of Action
[see Microbiology ( )] .
Worked on AUGMENTIN '125' at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.